EUVIMEDEUVIMED entdecken
MetaanalyseVergleichsstudieSystematische Übersicht

Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials

Takaomi Kobayashi, Tadatsugu Morimoto, Koji Ito, Masaaki Mawatari, Takafumi Shimazaki

Osteoporosis International · 2024-08 · 35 (8) · 1377-1393

DOI: 10.1007/s00198-024-07118-0 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Osteoporosis International, online erschienen am 11.05.2024. Verfasst von Takaomi Kobayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Taku City Hospital, Saga, Japan. takaomi_920@yahoo.co.jp. Hauptthemen laut MEDLINE: Denosumab, Diphosphonates, Bone Density Conservation Agents, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 95 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DenosumabDiphosphonatesBone Density Conservation AgentsRandomized Controlled Trials as TopicOsteoporosisHumansOsteoporotic Fractures

Stichwörter der Autor:innen

Adverse eventAlendronateBisphosphonateDenosumabIbandronateOsteoporosisRisedronateSafetyZoledronic acid

Substanzen

DenosumabDiphosphonatesBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Taku City Hospital, Saga, Japan. takaomi_920@yahoo.co.jp.
  • Department of Orthopaedic Surgery, Faculty of Medicine, Saga University, Saga, Japan. takaomi_920@yahoo.co.jp.
  • Department of Preventive Medicine, Faculty of Medicine, Saga University, Saga, Japan. takaomi_920@yahoo.co.jp.
  • Department of Clinical Research, Amagi Chuo Hospital, Fukuoka, Japan. takaomi_920@yahoo.co.jp.
  • Department of Orthopaedic Surgery, Faculty of Medicine, Saga University, Saga, Japan.
  • Department of Orthopaedic Surgery, Taku City Hospital, Saga, Japan.

Zitieren

APA

Kobayashi, T., Morimoto, T., Ito, K., Mawatari, M., & Shimazaki, T. (2024). Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials. Osteoporosis International, 35(8), 1377-1393. https://doi.org/10.1007/s00198-024-07118-0

Vancouver

Kobayashi T, Morimoto T, Ito K, Mawatari M, Shimazaki T. Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials. Osteoporosis International. 2024;35(8):1377-1393. doi:10.1007/s00198-024-07118-0

BibTeX
@article{Kobayashi2024,
  author = {Kobayashi, Takaomi and Morimoto, Tadatsugu and Ito, Koji and Mawatari, Masaaki and Shimazaki, Takafumi},
  title = {Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials},
  journal = {Osteoporosis International},
  year = {2024},
  volume = {35},
  number = {8},
  pages = {1377--1393},
  doi = {10.1007/s00198-024-07118-0}
}
Kostenlos starten →